NASDAQ:HEXOHEXO Stock Price, Forecast & News

HEXO's stock was trading at $0.9376 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HEXO shares have decreased by 22.1% and is now trading at $0.73. View which stocks have been most impacted by Coronavirus.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 10 sell ratings, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for HEXO.

HEXO is scheduled to release its next quarterly earnings announcement on Thursday, June 11th 2020. View our earnings forecast for HEXO.

HEXO Corp. (NASDAQ:HEXO) issued its earnings results on Monday, March, 30th. The company reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.06) by $0.02. The company earned $12.89 million during the quarter, compared to analyst estimates of $12.21 million. View HEXO's earnings history.

18 brokers have issued 1 year target prices for HEXO's shares. Their forecasts range from $1.00 to $4.00. On average, they expect HEXO's share price to reach $1.70 in the next twelve months. This suggests a possible upside of 132.5% from the stock's current price. View analysts' price targets for HEXO.

News stories about HEXO stock have trended very negative on Friday, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. HEXO earned a news impact score of -3.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news aboutHEXO.

Some companies that are related to HEXO include Knight Therapeutics (GUD), Ecofibre (EOF), HLS Therapeutics (HLS), OrganiGram (OGI), Next Science (NXS), ICC Labs (ICC), Amryt Pharma (AMYT), Benchmark (BMK), ESSA Pharma (EPI), Probiotec (PBP), Green Organic Dutchman (TGOD), WeedMD (WMD), CannTrust (TRST), Supreme Cannabis (FIRE) and Shield Therapeutics (STX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), OrganiGram (OGI), Aurora Cannabis (ACB), Tilray (TLRY), Charlotte's Web (CWBHF), NVIDIA (NVDA) and Alibaba Group (BABA).

HEXO trades on the NASDAQ under the ticker symbol "HEXO."

HEXO's stock is owned by a number of retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (6.02%), Morgan Stanley (0.72%), Public Sector Pension Investment Board (0.21%), AdvisorShares Investments LLC (0.04%), CLARET ASSET MANAGEMENT Corp (0.05%) and Toronto Dominion Bank (0.02%).

HEXO stock was sold by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Jane Street Group LLC, Sigma Planning Corp, and Toronto Dominion Bank.

HEXO stock was bought by a variety of institutional investors in the last quarter, including ETF Managers Group LLC, Morgan Stanley, Public Sector Pension Investment Board, CLARET ASSET MANAGEMENT Corp, UBS Group AG, and Advisor Group Holdings Inc..

Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of HEXO stock can currently be purchased for approximately $0.73.

HEXO has a market capitalization of $297.73 million.

The official website for HEXO is hexo.com.

The company can be reached via phone at 844-406-1852.